CIK 0001576885 · <br>Emerging growth company
Acumen Pharmaceuticals, Inc.
Sign in to watch- Ticker
- ABOS
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 364108129
- Phone
- 617-344-4190
- Business address
- 1210-1220 WASHINGTON STREET, SUITE 210, NEWTON, MA, 02465
- 4 Planned sale Chief Executive Officer sold 12,619 shares at $1.59 ($20,102)
- 4 Planned sale Chief Legal Officer & Corp Sec sold 3,418 shares at $1.59 ($5,435)
- 4 Planned sale Chief Operating Officer sold 2,914 shares at $1.61 ($4,692)
- 4 Planned sale Chief Medical Officer sold 3,219 shares at $1.59 ($5,118)
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 4 Planned sale Chief Executive Officer sold 47,778 shares at $1.84 ($87,873)
- 4 Grant or award Chief Regulatory Officer acquired 8,800 shares (grant or award)
- 4 Grant or award President and CDO acquired 62,600 shares (grant or award)
- 4 Planned sale Chief Legal Officer & Corp Sec sold 11,122 shares at $1.84 ($20,506)
- 4 Planned sale Chief Operating Officer sold 7,636 shares at $1.86 ($14,225)
- 4 Planned sale CFO & Chief Business Officer sold 13,235 shares at $1.84 ($24,367)
- 4 Planned sale Chief Medical Officer sold 10,859 shares at $1.85 ($20,047)
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
Page 8 of 19 · 365 filings